13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 23 of 30

Page 23 of 30 – SEC Filing


AEF LP
(a) Amount Beneficially Owned:
By virtue of its ownership of 30.90% of the equity interest in AEMF, AEF LP may be deemed to beneficially own the 1,310,494 Shares of the Companys Common Stock beneficially owned by AEMF.
(b) Percent of Class:
6.11%
(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct vote:
1,310,494
(ii) Shared power to vote or to direct vote:
None
(iii) Sole power to dispose or direct disposition of:
1,310,494
(iv) Shared power to dispose or to direct disposition of:
None
AEF LTD
(a) Amount Beneficially Owned:
By virtue of its ownership of 69.09% of the equity interest in AEMF, AEF LTD may be deemed to beneficially own the 1,310,494 Shares of the Companys Common Stock beneficially owned by AEMF.
(b) Percent of Class:
6.11%

Page 23 of 30 Pages

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 23 of 30